Open-mkt buys · 90d
$46.8K
4 trades · 1 insiders
Open-mkt sales · 90d
$10.2K
6 trades · 3 insiders
Net · 90d
$36.6K
Insiders on file
15
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Reid Laurence | Director | 6 | $46.8K | $0 | 2026-09-09 |
| Wein Matthew | See Remarks | 17 | $0 | $5.1K | 2026-09-08 |
| Irish Jian | See Remarks, Director | 17 | $0 | $29.3K | 2026-09-08 |
| Wapnick Pamela | Chief Financial Officer | 17 | $0 | $43.4K | 2026-09-08 |
| Eckhardt Juergen | Director | 3 | $0 | $0 | 2026-06-09 |
| Dere Willard H | Director | 3 | $0 | $0 | 2026-06-09 |
| BJERKHOLT ERIC | Director | 3 | $0 | $0 | 2026-06-09 |
| Thomas Brian C. | Director | 7 | $0 | $30.5K | 2025-12-05 |
| Noonberg Sarah B. | Chief Medical Officer | 5 | $0 | $9.2K | 2025-06-06 |
| Delaney Simren | See Remarks | 2 | $0 | $0 | 2024-04-01 |
| Harnest Simon | See Remarks | 2 | $0 | $0 | 2024-04-01 |
| Bernales Sebastian | Director | 9 | $0 | $0 | 2024-04-01 |
| Borges Luis | Chief Scientific Officer | 2 | $0 | $0 | 2024-04-01 |
| Bayer World Investments B.V. | 10% Owner | 8 | $0 | $0 | 2024-02-13 |
| Novo Holdings A/S | 10% Owner | 5 | $13.03M | $0 | 2024-02-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Reid Laurence | Director | P Buy | 2026-09-09 | 2026-09-11 | 117 | $1.18 | $138 | 20,000 | SEC↗ |
| Reid Laurence | Director | P Buy | 2026-09-09 | 2026-09-11 | 19,883 | $1.17 | $23.3K | 19,883 | SEC↗ |
| Reid Laurence | Director | P Buy | 2026-09-09 | 2026-09-11 | 117 | $1.18 | $138 | 20,000 | SEC↗ |
| Reid Laurence | Director | P Buy | 2026-09-09 | 2026-09-11 | 19,883 | $1.17 | $23.3K | 19,883 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2026-09-08 | 2026-09-10 | 1,911 | $1.16 | $2.2K | 206,580 | SEC↗ |
| Irish Jian | See Remarks | S Sale | 2026-09-08 | 2026-09-10 | 2,140 | $1.16 | $2.5K | 375,393 | SEC↗ |
| Wein Matthew | See Remarks | S Sale | 2026-09-08 | 2026-09-10 | 358 | $1.16 | $415 | 126,133 | SEC↗ |
| Wein Matthew | See Remarks | S Sale | 2026-09-08 | 2026-09-10 | 358 | $1.16 | $415 | 126,133 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2026-09-08 | 2026-09-10 | 1,911 | $1.16 | $2.2K | 206,580 | SEC↗ |
| Irish Jian | See Remarks, Director | S Sale | 2026-09-08 | 2026-09-10 | 2,140 | $1.16 | $2.5K | 375,393 | SEC↗ |
| Eckhardt Juergen | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 21,000 | — | $0 | 21,000 | SEC↗ |
| BJERKHOLT ERIC | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Dere Willard H | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Reid Laurence | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 17,400 | — | $0 | 17,400 | SEC↗ |
| Wein Matthew | See Remarks | S Sale | 2026-06-05 | 2026-06-10 | 558 | $1.30 | $725 | 126,491 | SEC↗ |
| Irish Jian | See Remarks | S Sale | 2026-06-05 | 2026-06-10 | 3,737 | $1.30 | $4.9K | 377,533 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2026-06-05 | 2026-06-10 | 2,884 | $1.30 | $3.7K | 208,491 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | A Award deriv | 2026-04-01 | 2026-04-03 | 144,000 | — | $0 | 144,000 | SEC↗ |
| Wein Matthew | See Remarks | A Award deriv | 2026-04-01 | 2026-04-03 | 68,000 | — | $0 | 68,000 | SEC↗ |
| Irish Jian | See Remarks | A Award deriv | 2026-04-01 | 2026-04-03 | 276,000 | — | $0 | 276,000 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | A Award | 2026-04-01 | 2026-04-03 | 24,000 | — | $0 | 211,375 | SEC↗ |
| Wein Matthew | See Remarks | A Award | 2026-04-01 | 2026-04-03 | 11,000 | — | $0 | 125,549 | SEC↗ |
| Irish Jian | See Remarks | A Award | 2026-04-01 | 2026-04-03 | 46,000 | — | $0 | 379,770 | SEC↗ |
| Irish Jian | Chief Executive Officer | S Sale | 2026-03-05 | 2026-03-09 | 1,607 | $1.60 | $2.6K | 333,770 | SEC↗ |
| Wein Matthew | See Remarks | S Sale | 2026-03-05 | 2026-03-09 | 482 | $1.60 | $771 | 114,549 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2026-03-05 | 2026-03-09 | 1,581 | $1.60 | $2.5K | 187,375 | SEC↗ |
| Irish Jian | Chief Executive Officer | G Gift | 2025-12-05 | 2026-03-09 | 228,462 | — | $0 | 335,377 | SEC↗ |
| Irish Jian | Chief Executive Officer | S Sale | 2025-12-05 | 2025-12-08 | 1,602 | $1.77 | $2.8K | 563,839 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2025-12-05 | 2025-12-08 | 1,576 | $1.77 | $2.8K | 188,956 | SEC↗ |
| Wein Matthew | See Remarks | S Sale | 2025-12-05 | 2025-12-08 | 199 | $1.77 | $352 | 115,031 | SEC↗ |
| Thomas Brian C. | Director | S Sale | 2025-12-05 | 2025-12-08 | 3,830 | $1.77 | $6.8K | 2,510,960 | SEC↗ |
| Irish Jian | Chief Executive Officer | A Award deriv | 2025-12-01 | 2025-12-01 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Wein Matthew | See Remarks | A Award | 2025-12-01 | 2025-12-01 | 96,000 | $1.60 | $153.6K | 115,230 | SEC↗ |
| Irish Jian | Chief Executive Officer | A Award | 2025-12-01 | 2025-12-01 | 211,000 | $1.60 | $337.6K | 565,441 | SEC↗ |
| Irish Jian | Chief Executive Officer | A Award | 2025-12-01 | 2025-12-01 | 37,500 | $1.60 | $60.0K | 354,441 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | A Award | 2025-12-01 | 2025-12-01 | 120,000 | $1.60 | $192.0K | 190,532 | SEC↗ |
| Wein Matthew | See Remarks | S Sale | 2025-09-05 | 2025-12-01 | 199 | $1.81 | $360 | 19,230 | SEC↗ |
| Irish Jian | Chief Executive Officer | S Sale | 2025-09-05 | 2025-12-01 | 1,602 | $1.81 | $2.9K | 316,941 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2025-09-05 | 2025-12-01 | 1,576 | $1.81 | $2.9K | 70,532 | SEC↗ |
| Thomas Brian C. | Director | S Sale | 2025-09-05 | 2025-12-01 | 2,701 | $1.81 | $4.9K | 2,514,790 | SEC↗ |
| Reid Laurence | Director | A Award deriv | 2025-09-02 | 2025-09-02 | 42,000 | — | $0 | 42,000 | SEC↗ |
| BJERKHOLT ERIC | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 8,572 | — | $0 | 8,572 | SEC↗ |
| Dere Willard H | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Eckhardt Juergen | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Irish Jian | See Remarks | S Sale | 2025-06-06 | 2025-06-09 | 6,390 | $1.75 | $11.2K | 315,543 | SEC↗ |
| Thomas Brian C. | Chief Executive Officer | S Sale | 2025-06-06 | 2025-06-09 | 10,785 | $1.75 | $18.9K | 2,517,491 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2025-06-06 | 2025-06-09 | 1,576 | $1.75 | $2.8K | 72,108 | SEC↗ |
| Noonberg Sarah B. | Chief Medical Officer | S Sale | 2025-06-06 | 2025-06-09 | 5,239 | $1.75 | $9.2K | 109,135 | SEC↗ |
| Wein Matthew | See Remarks | S Sale | 2025-06-06 | 2025-06-09 | 199 | $1.75 | $348 | 16,693 | SEC↗ |
| Noonberg Sarah B. | Chief Medical Officer | A Award deriv | 2025-04-01 | 2025-04-03 | 84,000 | — | $0 | 84,000 | SEC↗ |
| Wein Matthew | See Remarks | A Award deriv | 2025-04-01 | 2025-04-03 | 22,725 | — | $0 | 22,725 | SEC↗ |
| Wein Matthew | See Remarks | A Award deriv | 2025-04-01 | 2025-04-03 | 21,875 | — | $0 | 21,875 | SEC↗ |
| Irish Jian | See Remarks | A Award deriv | 2025-04-01 | 2025-04-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Thomas Brian C. | Chief Executive Officer | A Award deriv | 2025-04-01 | 2025-04-03 | 196,000 | — | $0 | 196,000 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | A Award deriv | 2025-04-01 | 2025-04-03 | 84,000 | — | $0 | 84,000 | SEC↗ |
| Noonberg Sarah B. | Chief Medical Officer | A Award | 2025-04-01 | 2025-04-03 | 14,000 | — | $0 | 114,374 | SEC↗ |
| Wein Matthew | See Remarks | A Award | 2025-04-01 | 2025-04-03 | 3,650 | — | $0 | 13,117 | SEC↗ |
| Wein Matthew | See Remarks | A Award | 2025-04-01 | 2025-04-03 | 3,775 | — | $0 | 16,892 | SEC↗ |
| Irish Jian | See Remarks | A Award | 2025-04-01 | 2025-04-03 | 23,000 | — | $0 | 321,933 | SEC↗ |
| Thomas Brian C. | Chief Executive Officer | A Award | 2025-04-01 | 2025-04-03 | 32,000 | — | $0 | 2,528,276 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | A Award | 2025-04-01 | 2025-04-03 | 14,000 | — | $0 | 73,684 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2025-03-05 | 2025-03-07 | 1,808 | $1.87 | $3.4K | 59,684 | SEC↗ |
| Wein Matthew | See Remarks | S Sale | 2025-03-05 | 2025-03-07 | 930 | $1.87 | $1.7K | 9,467 | SEC↗ |
| BJERKHOLT ERIC | Director | A Award deriv | 2025-02-03 | 2025-02-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2024-12-05 | 2024-12-06 | 1,559 | $1.86 | $2.9K | 61,492 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | S Sale | 2024-09-05 | 2024-09-06 | 6,265 | $2.88 | $18.0K | 63,051 | SEC↗ |
| Thomas Brian C. | Chief Executive Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 500,323 | — | $0 | 500,323 | SEC↗ |
| Dere Willard H | Director | A Award deriv | 2024-04-01 | 2024-04-03 | 78,636 | — | $0 | 78,636 | SEC↗ |
| Delaney Simren | See Remarks | A Award deriv | 2024-04-01 | 2024-04-03 | 29,145 | — | $0 | 29,145 | SEC↗ |
| Harnest Simon | See Remarks | A Award deriv | 2024-04-01 | 2024-04-03 | 48,575 | — | $0 | 48,575 | SEC↗ |
| Bernales Sebastian | Director | A Award deriv | 2024-04-01 | 2024-04-03 | 78,636 | — | $0 | 78,636 | SEC↗ |
| Noonberg Sarah B. | Chief Medical Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 242,875 | — | $0 | 242,875 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 291,450 | — | $0 | 291,450 | SEC↗ |
| Wein Matthew | See Remarks | A Award deriv | 2024-04-01 | 2024-04-03 | 43,717 | — | $0 | 43,717 | SEC↗ |
| Borges Luis | Chief Scientific Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 291,450 | — | $0 | 291,450 | SEC↗ |
| Eckhardt Juergen | Director | A Award deriv | 2024-04-01 | 2024-04-03 | 78,636 | — | $0 | 78,636 | SEC↗ |
| Irish Jian | See Remarks | A Award deriv | 2024-04-01 | 2024-04-03 | 296,308 | — | $0 | 296,308 | SEC↗ |
| Thomas Brian C. | Chief Executive Officer | A Award | 2024-04-01 | 2024-04-03 | 118,992 | — | $0 | 2,496,276 | SEC↗ |
| Delaney Simren | See Remarks | A Award | 2024-04-01 | 2024-04-03 | 6,931 | — | $0 | 93,892 | SEC↗ |
| Harnest Simon | See Remarks | A Award | 2024-04-01 | 2024-04-03 | 11,552 | — | $0 | 122,664 | SEC↗ |
| Noonberg Sarah B. | Chief Medical Officer | A Award | 2024-04-01 | 2024-04-03 | 57,763 | — | $0 | 100,374 | SEC↗ |
| Wapnick Pamela | Chief Financial Officer | A Award | 2024-04-01 | 2024-04-03 | 69,316 | — | $0 | 69,316 | SEC↗ |
| Wein Matthew | See Remarks | A Award | 2024-04-01 | 2024-04-03 | 10,397 | — | $0 | 10,397 | SEC↗ |
| Borges Luis | Chief Scientific Officer | A Award | 2024-04-01 | 2024-04-03 | 69,316 | — | $0 | 69,316 | SEC↗ |
| Irish Jian | See Remarks | A Award | 2024-04-01 | 2024-04-03 | 70,471 | — | $0 | 298,933 | SEC↗ |
| Bernales Sebastian | Director | C Conversion deriv | 2024-02-13 | 2024-02-14 | 353,005 | — | $0 | 0 | SEC↗ |
| Bernales Sebastian | Director | C Conversion deriv | 2024-02-13 | 2024-02-14 | 106,627 | — | $0 | 0 | SEC↗ |
| Bernales Sebastian | Director | C Conversion deriv | 2024-02-13 | 2024-02-14 | 1,143,905 | — | $0 | 0 | SEC↗ |
| Bernales Sebastian | Director | C Conversion deriv | 2024-02-13 | 2024-02-14 | 2,062,387 | — | $0 | 0 | SEC↗ |
| Bernales Sebastian | Director | C Conversion deriv | 2024-02-13 | 2024-02-14 | 423,469 | — | $0 | 0 | SEC↗ |
| Bernales Sebastian | Director | C Conversion deriv | 2024-02-13 | 2024-02-14 | 119,699 | — | $0 | 0 | SEC↗ |
| Bayer World Investments B.V. | 10% Owner | C Conversion deriv | 2024-02-13 | 2024-02-15 | 2,062,387 | — | $0 | 0 | SEC↗ |
| Bayer World Investments B.V. | 10% Owner | C Conversion deriv | 2024-02-13 | 2024-02-15 | 1,030,086 | — | $0 | 0 | SEC↗ |
| Bayer World Investments B.V. | 10% Owner | C Conversion deriv | 2024-02-13 | 2024-02-15 | 890,671 | — | $0 | 0 | SEC↗ |
| Bayer World Investments B.V. | 10% Owner | C Conversion deriv | 2024-02-13 | 2024-02-15 | 3,093,580 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2024-02-13 | 2024-02-15 | 691,760 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2024-02-13 | 2024-02-15 | 147,415 | — | $0 | 0 | SEC↗ |
| Bernales Sebastian | Director | C Conversion | 2024-02-13 | 2024-02-14 | 1,896,445 | — | $0 | 1,896,445 | SEC↗ |
| Bernales Sebastian | Director | C Conversion | 2024-02-13 | 2024-02-14 | 513,004 | — | $0 | 769,845 | SEC↗ |
| Bayer World Investments B.V. | 10% Owner | C Conversion | 2024-02-13 | 2024-02-15 | 509,855 | — | $0 | 4,050,997 | SEC↗ |
| Bayer World Investments B.V. | 10% Owner | C Conversion | 2024-02-13 | 2024-02-15 | 1,770,888 | — | $0 | 1,770,888 | SEC↗ |
| Bayer World Investments B.V. | 10% Owner | C Conversion | 2024-02-13 | 2024-02-15 | 1,180,592 | — | $0 | 2,951,480 | SEC↗ |
| Bayer World Investments B.V. | 10% Owner | C Conversion | 2024-02-13 | 2024-02-15 | 589,662 | — | $0 | 3,541,142 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion | 2024-02-13 | 2024-02-15 | 839,175 | — | $0 | 939,175 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2024-02-13 | 2024-02-15 | 800,000 | $15.00 | $12.00M | 1,739,175 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2024-02-09 | 2024-02-15 | 100,000 | $10.25 | $1.02M | 100,000 | SEC↗ |